JOHNS HOPKINS UNIVERSITY

🇳🇦Namibia

Country: 🇳🇦Namibia

Ownership: -

Established: 1876-01-01

Employees: 19.4K

Market Cap: -

Website: https://www.jhu.edu/

Clinical Trials

Evaluation of Nicotinamide Riboside in Prevention of Small Fiber Axon Degeneration and Promotion of Nerve Regeneration

Phase 2

Completed

Conditions: Small Fiber Neuropathy

Interventions: Drug: Placebo Oral Tablet
Drug: Nicotinamide riboside

First Posted Date: 2019-04-11

Last Posted Date: 2024-06-12

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 45

Registration Number: NCT03912220

Locations: 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States

PLAN: Dementia Literacy Education and Navigation for Korean Elders With Probable Dementia and Their Caregivers

Not Applicable

Recruiting

Conditions: Dementia

Interventions: Behavioral: PLAN
Behavioral: Standard of Care

First Posted Date: 2019-04-10

Last Posted Date: 2025-03-07

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 288

Registration Number: NCT03909347

Locations: 🇺🇸
Korean Community Services of Metropolitan New York, Bayside, New York, United States
🇺🇸
Korean Community Service Center of Greater Washington, Annandale, Virginia, United States

Examining the Feasibility of the Ask RoSE Mobile Mental Health Application

Not Applicable

Withdrawn

Conditions: Mental Health Wellness 1
Anxiety

Interventions: Behavioral: Mobile Mental Health App

First Posted Date: 2019-04-10

Last Posted Date: 2022-08-26

Lead Sponsor: Johns Hopkins University

Registration Number: NCT03909685

MEMORI Corps: Activity-based Companion Care for Dementia

Not Applicable

Completed

Conditions: Alzheimer Disease
Dementia

Interventions: Behavioral: MEMORI Corps program
Other: Augmented Waitlist Control

First Posted Date: 2019-04-01

Last Posted Date: 2024-10-01

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 175

Registration Number: NCT03896711

Locations: 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States

Targeting Language-specific and Executive-control Networks With Transcranial Direct Current Stimulation in Logopenic Variant PPA

Not Applicable

Recruiting

Conditions: Logopenic Progressive Aphasia
Primary Progressive Aphasia

Interventions: Device: High-definition active tDCS (HD-tDCS) + "Repeat After Me" (RAM) Treatment
Device: Sham + "Repeat After Me" (RAM) Treatment

First Posted Date: 2019-03-25

Last Posted Date: 2023-12-01

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 60

Registration Number: NCT03887481

Locations: 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States

A Percutaneous Ultrasound Device With Needle Guide for Vascular Access

Not Applicable

Suspended

Conditions: Vascular Access

Interventions: Device: Vu-Path™

First Posted Date: 2019-03-18

Last Posted Date: 2024-10-23

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 30

Registration Number: NCT03879161

Locations: 🇺🇸
Johns Hopkins School of Medicine, Baltimore, Maryland, United States

Ocrelizumab Effects on the Metabolome in MS

Completed

Conditions: Multiple Sclerosis

Interventions: Drug: Ocrelizumab

First Posted Date: 2019-03-13

Last Posted Date: 2023-12-12

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 25

Registration Number: NCT03873389

Locations: 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States

PICU Up!: A Pilot Stepped-wedge Trial of a Multicomponent Early Mobility Intervention for Critically Ill Children

Not Applicable

Active, not recruiting

Conditions: Critical Illness

Interventions: Other: PICU Up!

First Posted Date: 2019-03-01

Last Posted Date: 2025-04-13

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 2500

Registration Number: NCT03860168

Locations: 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States

Improving Wisely - Polypharmacy

Not Applicable

Completed

Conditions: Adverse Drug Event

Interventions: Other: Audit and feedback - letter and report

First Posted Date: 2019-02-27

Last Posted Date: 2021-02-23

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 11000

Registration Number: NCT03857100

Locations: 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States

Short-term B-cell Depletion in Relapsing Multiple Sclerosis

Phase 4

Completed

Conditions: Multiple Sclerosis

Interventions: Drug: Ocrelizumab

First Posted Date: 2019-02-26

Last Posted Date: 2025-02-05

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 10

Registration Number: NCT03853746

Locations: 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy